v3.26.1
Business Segments and Concentrations (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Segment Financial Information
The following tables set forth financial information by segment:
Three months ended June 30, 2026Consumer Products segmentIngredients segmentAnalytical Reference Standards and Services segmentPharmaceuticals segmentCorporate and other (1)Total
(In thousands)
Net sales$24,162 $5,387 $— $— $236 $29,785 
Cost of sales7,839 2,374 — — 258 10,471 
Gross profit (loss)16,323 3,013 — — (22)19,314 
Operating expenses:
Sales and marketing
Advertising3,166 — — — — 3,166 
Marketing3,712 180 — — — 3,892 
Selling3,032 40 — — — 3,072 
Research and development841 191 — 481 — 1,513 
General and administrative (2)— — — — 6,971 6,971 
Operating expenses10,751 411 — 481 6,971 18,614 
Operating income (loss)$5,572 $2,602 $— $(481)$(6,993)$700 
(1) Includes TSA activity related to the disposition of the Analytical Reference Standards and Services operating segment, which is reflected in net sales, cost of sales and gross profit.
(2) General and administrative expenses within “Corporate and other” represent ongoing corporate overhead and are not directly attributable to TSA activities.

Three months ended June 30, 2025Consumer Products segmentIngredients segmentAnalytical Reference Standards and Services segmentPharmaceuticals segmentCorporate and otherTotal
(In thousands)
Net sales$22,699 $7,619 $799 $— $— $31,117 
Cost of sales7,453 2,808 630 — — 10,891 
Gross profit15,246 4,811 169 — — 20,226 
Operating expenses:
Sales and marketing
Advertising2,882 — — — — 2,882 
Marketing2,514 45 — — — 2,559 
Selling 2,678 7 81 — — 2,766 
Research and development891 304 — 372 — 1,567 
General and administrative— — — — 7,267 7,267 
Operating expenses8,965 356 81 372 7,267 17,041 
Operating income (loss)$6,281 $4,455 $88 $(372)$(7,267)$3,185 
Six Months Ended June 30, 2026Consumer Products segmentIngredients segmentAnalytical Reference Standards and Services segmentPharmaceuticals segmentCorporate and other (1)Total
(In thousands)
Net sales$46,575 $13,951 $423 $— $310 $61,259 
Cost of sales15,434 5,929 308 — 298 21,969 
Gross profit31,141 8,022 115 — 12 39,290 
Operating expenses:
Sales and marketing
Advertising6,458 — — — — 6,458 
Marketing7,134 276 — — — 7,410 
Selling5,759 134 44 — — 5,937 
Research and development1,574 471 — 949 — 2,994 
General and administrative (2)— — — — 14,215 14,215 
Operating expenses20,925 881 44 949 14,215 37,014 
Operating income (loss)$10,216 $7,141 $71 $(949)$(14,203)$2,276 
(1) Includes TSA activity related to the disposition of the Analytical Reference Standards and Services operating segment, which is reflected in net sales, cost of sales and gross profit.
(2) General and administrative expenses within “Corporate and other” represent ongoing corporate overhead and are not directly attributable to TSA activities.
Six Months Ended June 30, 2025Consumer Products segmentIngredients segmentAnalytical Reference Standards and Services segmentPharmaceuticals segmentCorporate and otherTotal
(In thousands)
Net sales$44,200 $15,788 $1,610 $— $— $61,598 
Cost of sales14,860 5,909 1,272 — — 22,041 
Gross profit
29,340 9,879 338 — — 39,557 
Operating expenses:
Sales and marketing
Advertising5,858 — — — — 5,858 
Marketing4,967 70 — — — 5,037 
Selling5,185 56 188 — — 5,429 
Research and development1,536 549 — 740 — 2,825 
General and administrative— — — — 12,451 12,451 
Operating expenses17,546 675 188 740 12,451 31,600 
Operating income (loss)$11,794 $9,204 $150 $(740)$(12,451)$7,957 
Schedule of Disaggregation of Revenue Disaggregated revenues are as follows:
Three Months Ended June 30, 2026Consumer Products SegmentIngredients SegmentAnalytical Reference Standards and Services SegmentCorporate and Other (1)Total
(In thousands)
Tru Niagen®, Consumer Product$24,162 $— $— $— $24,162 
Food-grade Niagen®
— 4,928 — — 4,928 
Pharmaceutical-grade Niagen®
— 425 — — 425 
Subtotal Niagen® Related24,162 5,353 — — 29,515 
Other Ingredients— 25 — — 25 
Reference Standards— — — — — 
Services and Other— 9 — 236 245 
Subtotal Other Goods and Services— 34 — 236 270 
Total Net Sales$24,162 $5,387 $— $236 $29,785 
(1) Includes TSA activity related to the disposition of the Analytical Reference Standards and Services operating segment.
Three Months Ended June 30, 2025Consumer Products SegmentIngredients SegmentAnalytical Reference Standards and Services SegmentTotal (1)
(In thousands)
Tru Niagen®, Consumer Product$22,699 $— $— $22,699 
Food-grade Niagen®
— 5,994 — 5,994 
Pharmaceutical-grade Niagen®— 1,390 — 1,390 
Subtotal Niagen® Related22,699 7,384 — 30,083 
Other Ingredients— 235 — 235 
Reference Standards— — 772 772 
Services and Other— — 27 27 
Subtotal Other Goods and Services— 235 799 1,034 
Total Net Sales$22,699 $7,619 $799 $31,117 
(1) Does not include TSA activity related to the disposition of the Analytical Reference Standards and Services operating segment, which is only applicable during 2026 as no such similar activity occurred in 2025.
Six Months Ended June 30, 2026Consumer Products SegmentIngredients SegmentAnalytical Reference Standards and Services SegmentCorporate and Other (1)Total
(In thousands)
Tru Niagen®, Consumer Product$46,575 $— $— $— $46,575 
Food-grade Niagen®
— 12,237 — — 12,237 
Pharmaceutical-grade Niagen®— 1,275 — — 1,275 
Subtotal Niagen® Related46,575 13,512 — — 60,087 
Other Ingredients— 430 — — 430 
Reference Standards— — 411 — 411 
Services and Other— 9 12 310 331 
Subtotal Other Goods and Services— 439 423 310 1,172 
Total Net Sales$46,575 $13,951 $423 $310 $61,259 
(1) Includes TSA activity related to the disposition of the Analytical Reference Standards and Services operating segment.

Six Months Ended June 30, 2025Consumer Products SegmentIngredients SegmentAnalytical Reference Standards and Services SegmentTotal (1)
(In thousands)
Tru Niagen®, Consumer Product$44,200 $— $— $44,200 
Food-grade Niagen®
— 12,968 — 12,968 
Pharmaceutical-grade Niagen®— 2,390 — 2,390 
Subtotal Niagen® Related44,200 15,358 — 59,558 
Other Ingredients— 430 — 430 
Reference Standards— — 1,570 1,570 
Services and Other— — 40 40 
Subtotal Other Goods and Services— 430 1,610 2,040 
Total Net Sales$44,200 $15,788 $1,610 $61,598 
(1) Does not include TSA activity related to the disposition of the Analytical Reference Standards and Services operating segment, which is only applicable during 2026 as no such similar activity occurred in 2025.
Schedule of Major Customers Percentage of net sales from major customers of the Company’s consumer products segment and ingredients segment for the periods indicated were as follows:
Three Months Ended June 30,Six Months Ended June 30,
Major Customers2026202520262025
Customer A*10.2 %*12.7 %
* Represents less than 10%
The percentage of the amounts due from major customers to total trade receivables, net for the periods indicated were as follows:
Percentage of the Company's Total Trade Receivables
Major CustomersAt June 30, 2026At December 31, 2025
Customer A11.1 %*
Customer B*23.0 %
Customer C26.1 %11.0 %
* Represents less than 10%